Skip to main content

Select Drug Profiles

Pooled Analysis of Safety Data from Phase 2 and 3 Clinical Trials Evaluating Eravacycline in Complicated Intra-Abdominal Infections

Integrated Safety Summary of Omadacycline, A Novel Aminomethylcycline Antibiotic

Antimicrobial Stewardship Program Aims to Reduce Antimicrobial Usage in Geriatric Patients without Affecting Outcomes

Longer Duration of Antibiotic Therapy for Community-Acquired Pneumonia and Risk for Clostridium Difficile Infection

New Robust Antimicrobial Stewardship Program Results in Reduction of Clostridium Difficile 30-Day Readmission

FDA Approves NUZYRA™ (Omadacycline) for Community-Acquired Bacterial Pneumonia and Acute Skin and Skin Structure Infections

Oral Step-Down Therapy with Fluoroquinolones versus Beta-Lactams for Hospitalized Patients with Community-Acquired Pneumonia

Unintended Consequences of Fluoroquinolone Stewardship: Impact on Overall Antimicrobial Use Data and Implications for Benchmarking

Pooled Analysis of Patients with Wound Infections in the Phase 3 REVIVE Trials Comparing Iclaprim with Vancomycin

Omadacycline for Acute Bacterial Skin and Skin Structure Infections: Integrated Analysis of Randomized Clinical Trials

Page 66 of 244
Results 651 - 660 of 2438